EP0243029A1
(en)
*
|
1986-04-08 |
1987-10-28 |
THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce |
Recombinant vaccinia virus expressing human retrovirus gene
|
US6054438A
(en)
*
|
1987-01-07 |
2000-04-25 |
Imperial Cancer Research Technology Limited |
Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
|
US5348741A
(en)
*
|
1987-02-03 |
1994-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vector for recombinant poxvirus expressing rabies virus glycoprotein
|
US5443964A
(en)
*
|
1987-08-10 |
1995-08-22 |
Duke University |
Poxvirus insertion/expression vector
|
US5578468A
(en)
*
|
1987-08-10 |
1996-11-26 |
Duke University |
Site-specific RNA cleavage
|
CA1341245C
(en)
*
|
1988-01-12 |
2001-06-05 |
F. Hoffmann-La Roche Ag |
Recombinant vaccinia virus mva
|
US5691170A
(en)
*
|
1989-04-18 |
1997-11-25 |
Therion Biologics |
Generation of hybrid genes and proteins by virus-mediated recombination
|
ES2199932T3
(es)
*
|
1989-06-21 |
2004-03-01 |
The Rockefeller University |
Poxvirus recombinante y vacuna estreptococica que contiene proteina m.
|
ATE103982T1
(de)
*
|
1990-01-26 |
1994-04-15 |
Immuno Ag |
Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
|
US5766597A
(en)
*
|
1991-03-07 |
1998-06-16 |
Virogenetics Corporation |
Malaria recombinant poxviruses
|
US5756101A
(en)
*
|
1991-07-01 |
1998-05-26 |
Pasteur Merieux Serums Et Vaccins |
Malaria recombinant poxvirus
|
JPH06505397A
(ja)
*
|
1991-03-20 |
1994-06-23 |
ヴァイロジェネティクス コーポレイション |
マラリア組換体ポックスウイルス
|
WO1992019266A1
(en)
*
|
1991-05-06 |
1992-11-12 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
|
US5736378A
(en)
*
|
1991-09-12 |
1998-04-07 |
The Scripps Research Institute |
Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
|
WO1994016737A1
(en)
*
|
1993-01-26 |
1994-08-04 |
Weiner David B |
Compositions and methods for delivery of genetic material
|
US5981505A
(en)
*
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
US5593972A
(en)
*
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
US7001759B1
(en)
|
1993-01-26 |
2006-02-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
US6348449B1
(en)
*
|
1993-09-21 |
2002-02-19 |
The Trustees Of The University Of Pennsylvania |
Methods of inducing mucosal immunity
|
US6093700A
(en)
*
|
1995-05-11 |
2000-07-25 |
Thomas Jefferson University |
Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF
|
DE69535288T2
(de)
*
|
1994-05-13 |
2007-04-05 |
Thomas Jefferson University |
Verfahren zur induzierung einer immunantwort mittels rekombinanten vaccinia-viren, die das gm-csf-gen exprimieren
|
AUPN658795A0
(en)
*
|
1995-11-15 |
1995-12-07 |
Commonwealth Scientific And Industrial Research Organisation |
Method of producing alpha 2, 3 sialyltransferase
|
ATE386811T1
(de)
|
1996-04-05 |
2008-03-15 |
Novartis Vaccines & Diagnostic |
Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
|
CA2254082C
(en)
*
|
1996-05-03 |
2012-09-11 |
Thomas Jefferson University |
Metastatic colorectal cancer vaccine
|
WO1998012332A1
(en)
|
1996-09-17 |
1998-03-26 |
Chiron Corporation |
Compositions and methods for treating intracellular diseases
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
WO1999006576A1
(en)
|
1997-08-04 |
1999-02-11 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
US7135333B1
(en)
|
1997-08-07 |
2006-11-14 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
US6120995A
(en)
*
|
1997-08-07 |
2000-09-19 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
DE69838483T2
(de)
|
1997-10-14 |
2008-07-03 |
Darwin Molecular Corp. |
Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
|
JP2002507387A
(ja)
|
1997-12-24 |
2002-03-12 |
コリクサ コーポレイション |
乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
|
IL138075A0
(en)
|
1998-02-27 |
2001-10-31 |
Univ Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
KR20010041992A
(ko)
|
1998-03-18 |
2001-05-25 |
길리스 스티브 |
폐암의 치료와 진단을 위한 화합물 및 이를 위한 방법
|
BR9912671A
(pt)
|
1998-08-07 |
2001-05-02 |
Univ Washington |
Antìgenos imunológicos para o vìrus de herpes simples e métodos para sua utilização
|
US6194178B1
(en)
|
1998-09-03 |
2001-02-27 |
Synsorb Biotech Inc. |
Method for the production of sialylated oligosaccharides
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
GB0400443D0
(en)
|
2004-01-09 |
2004-02-11 |
Oxford Biomedica Ltd |
Cascade
|
US7148035B1
(en)
|
1998-11-18 |
2006-12-12 |
Oxford Biomedica (Uk) Limited |
Polypeptide
|
EP2042598A1
(en)
|
1998-11-18 |
2009-04-01 |
Oxford Biomedica (UK) Limited |
5T4 tumour-associated antigen for use in tumour immunotherapy
|
IL143531A0
(en)
|
1998-12-08 |
2002-04-21 |
Corixa Corp |
Polypeptides containing an antigenic portion of a chlamydia antigen, dna sequences encoding said polypeptides and pharmaceutical compositions and vaccines containing the same
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
EP1168918A4
(en)
*
|
1999-03-03 |
2002-08-21 |
Univ Pennsylvania |
VACCINE AND GENE THERAPY COMPOSITIONS AND METHOD FOR THEIR PRODUCTION AND USE
|
US6864235B1
(en)
*
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
ES2308976T3
(es)
|
1999-04-02 |
2008-12-16 |
Corixa Corporation |
Compuestos y metodos para la terapia y el diagnostico del cancer de pulmon.
|
JP2002542800A
(ja)
*
|
1999-04-30 |
2002-12-17 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア |
変異体ヒトcd80および組成物およびその作製および使用法
|
US20030232060A1
(en)
*
|
1999-07-28 |
2003-12-18 |
Smith Stephen M. |
Attenuated, doxycycline-inducible human immunodeficiency virus proviral molecular clones
|
CA2400842C
(en)
|
2000-02-23 |
2013-01-15 |
Smithkline Beecham Biologicals S.A. |
Novel compounds
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US7575860B2
(en)
*
|
2000-03-07 |
2009-08-18 |
Evans David H |
DNA joining method
|
DE60142228D1
(de)
|
2000-03-27 |
2010-07-08 |
Univ Jefferson |
Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal
|
EP1278855B1
(en)
|
2000-04-21 |
2008-03-12 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
EP1284740B1
(en)
|
2000-05-19 |
2008-05-21 |
Corixa Corporation |
Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
CA2413959C
(en)
|
2000-06-20 |
2015-07-07 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
WO2002000174A2
(en)
|
2000-06-28 |
2002-01-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
DE60134408D1
(de)
*
|
2000-07-14 |
2008-07-24 |
Univ Pennsylvania |
Für akzessorische hiv proteine kodierende dna impfstoffe
|
US7829276B2
(en)
*
|
2000-09-18 |
2010-11-09 |
Thomas Jefferson University |
Methods of using CRCA-1 as a stomach and esophageal cancer marker
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
US7691821B2
(en)
|
2001-09-19 |
2010-04-06 |
University Of South Florida |
Inhibition of SHIP to enhance stem cell harvest and transplantation
|
JP2004510714A
(ja)
*
|
2000-10-04 |
2004-04-08 |
ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア |
フラビウイルス及びペスチウイルス由来のキャプシド蛋白質を使用する組成物及び方法
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
CN1911965B
(zh)
|
2001-01-17 |
2013-05-29 |
新兴产品开发西雅图有限公司 |
结合域-免疫球蛋白融合蛋白
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
EP1988097A1
(en)
|
2001-05-09 |
2008-11-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US8216585B2
(en)
*
|
2001-05-25 |
2012-07-10 |
The Trustees Of The University Of Pennsylvania |
Targeted particles and methods of using the same
|
WO2003053220A2
(en)
|
2001-12-17 |
2003-07-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
GB0203420D0
(en)
|
2002-02-13 |
2002-04-03 |
Oxford Biomedica Ltd |
Peptide
|
GB0203419D0
(en)
|
2002-02-13 |
2002-04-03 |
Oxford Biomedica Ltd |
Peptide
|
US20030206916A1
(en)
*
|
2002-05-03 |
2003-11-06 |
Rush-Presbyterian-St. Luke's Medical Center |
Immunogenic peptides
|
DE60324678D1
(de)
|
2002-07-18 |
2008-12-24 |
Univ Washington |
N t-lymphozyten und damit identifizierte hsv-antigene
|
US20070224124A1
(en)
*
|
2002-09-30 |
2007-09-27 |
University Of South Florida |
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
|
EP1633786A4
(en)
*
|
2002-10-09 |
2007-07-25 |
Rinat Neuroscience Corp |
METHOD FOR TREATING ALZHEIMER DISEASE WITH ANTIBODIES TO AMYLOID BETA PEPTIDE AND COMPOSITIONS THEREOF
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
HUE026376T2
(en)
|
2003-01-06 |
2016-05-30 |
Corixa Corp |
Certain aminoalkyl glucosamide phosphate compounds and their use
|
EP2359851A3
(en)
|
2003-03-28 |
2011-08-31 |
The Government of the United States of America, represented by The Secretary, Department of Health and Human Services |
MVA expressing modified hiv envelope, gag, and pol genes
|
WO2004112706A2
(en)
|
2003-06-13 |
2004-12-29 |
The Trustees Of The University Of Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
NZ570709A
(en)
*
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
WO2005007673A2
(en)
*
|
2003-07-03 |
2005-01-27 |
Rush University Medical Center |
Immunogenic peptides
|
WO2005012528A1
(fr)
*
|
2003-08-01 |
2005-02-10 |
Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences |
Methode de preparation d'un vaccin a partir d'un gene chimere a epitopes
|
US7763592B1
(en)
|
2003-11-20 |
2010-07-27 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US7807646B1
(en)
*
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
WO2006019906A1
(en)
|
2004-07-14 |
2006-02-23 |
The Regents Of The University Of California |
Biomarker for early detection of ovarian cancer
|
EP2298807A3
(en)
*
|
2004-07-30 |
2011-05-18 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
CA2579764A1
(en)
|
2004-08-10 |
2006-02-23 |
Institute For Multiple Myeloma And Bone Cancer Research |
Methods of regulating differentiation and treating of multiple myeloma
|
DK1789438T3
(en)
|
2004-08-27 |
2015-07-20 |
Us Government |
Recombinant MVA viruses expressing MODIFIED env, gag and pol genes of HIV CLADE A / G, CLADE CLADE B AND C
|
EP2305294B1
(en)
|
2004-09-22 |
2015-04-01 |
GlaxoSmithKline Biologicals SA |
Immunogenic composition for use in vaccination against staphylococcei
|
DK3312272T3
(da)
|
2004-10-08 |
2019-12-02 |
Us Gov Health & Human Services |
Modulering af replikationstilpasning ved brug a mindre optrædende synonyme kodoner
|
WO2007050095A2
(en)
|
2004-11-19 |
2007-05-03 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines and methods for using the same
|
EP1701165A1
(en)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
|
EP2392349A3
(en)
|
2005-03-31 |
2012-01-18 |
GlaxoSmithKline Biologicals S.A. |
Vaccines against chlamydial infection
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
ES2381492T3
(es)
|
2005-04-29 |
2012-05-28 |
Glaxosmithkline Biologicals Sa |
Procedimiento de prevención o tratamiento de infección por M. tuberculosis
|
JP4926168B2
(ja)
|
2005-05-13 |
2012-05-09 |
オックスフォード バイオメディカ(ユーケー)リミテッド |
ペプチド
|
RU2486204C2
(ru)
*
|
2005-07-22 |
2013-06-27 |
Уай'З Терапьютикс Ко., Лтд. |
Антитела против сd26 и способы их применения
|
UA97469C2
(uk)
|
2005-07-25 |
2012-02-27 |
Емерджент Продакт Дівелопмент Сіетл, Елелсі |
Гуманізована специфічна до cd37 зв'язувальна молекула імуноглобуліну
|
WO2007016597A2
(en)
*
|
2005-07-29 |
2007-02-08 |
The Regents Of The University Of California |
Targeting tnf-alpha converting enzyme (tace)-dependent growth factor shedding in cancer therapy
|
EP2357000A1
(en)
|
2005-10-18 |
2011-08-17 |
Novartis Vaccines and Diagnostics, Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
CA2636424A1
(en)
|
2006-01-09 |
2007-10-25 |
The Regents Of The University Of California |
Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agonists for vaccines and tumor immunotherapy
|
KR101421745B1
(ko)
*
|
2006-01-13 |
2014-07-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
코돈 최적화된 il―15를 사용하는 백신 및 면역치료제, 및 그의 사용 방법
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
US8524454B2
(en)
|
2006-04-07 |
2013-09-03 |
The Research Foundation Of State University Of New York |
Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
|
NZ573646A
(en)
|
2006-06-12 |
2012-04-27 |
Wyeth Llc |
Single-chain multivalent binding proteins with effector function
|
CN105063064A
(zh)
|
2006-07-28 |
2015-11-18 |
宾夕法尼亚大学托管会 |
改进的疫苗及其使用方法
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
EP2468300B1
(en)
|
2006-09-26 |
2017-12-20 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
WO2009006479A2
(en)
|
2007-07-02 |
2009-01-08 |
Etubics Corporation |
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
|
WO2009023386A2
(en)
*
|
2007-07-06 |
2009-02-19 |
Trubion Pharmaceuticals, Inc. |
Binding peptides having a c-terminally disposed specific binding domain
|
CA2720168C
(en)
|
2008-04-04 |
2024-04-30 |
David B. Weiner |
Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
|
US8852609B2
(en)
*
|
2008-04-04 |
2014-10-07 |
The Trustees Of The University Of Pennsylvania |
Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
|
AU2009234389B2
(en)
|
2008-04-10 |
2014-08-21 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR mutations in cancer
|
NZ603059A
(en)
*
|
2008-04-11 |
2014-07-25 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
US20110206736A1
(en)
*
|
2008-09-23 |
2011-08-25 |
Thomas Jefferson University |
Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same
|
WO2010050939A1
(en)
|
2008-10-29 |
2010-05-06 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
CA2653478A1
(en)
*
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
CN102481312B
(zh)
|
2009-06-05 |
2015-07-15 |
传染性疾病研究院 |
合成的吡喃葡萄糖脂佐剂
|
KR20120093163A
(ko)
|
2009-09-14 |
2012-08-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Il-15 수용체 알파 및/또는 이를 인코딩하는 핵산 분자를 포함하는 백신 및 면역 치료제, 및 이를 이용하는 방법
|
EP3444333A1
(en)
|
2009-10-22 |
2019-02-20 |
Thomas Jefferson University |
Cell-based anti-cancer compositions and methods of making and using the same
|
KR102138780B1
(ko)
|
2009-11-02 |
2020-07-29 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
구제역 바이러스(fmdv) 공통 단백질, 이를 위한 코딩 서열 및 이로부터 만들어진 백신
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
DK2528621T3
(da)
|
2010-01-27 |
2017-01-02 |
Glaxosmithkline Biologicals Sa |
Modificerede tuberkuloseantigener
|
KR101784177B1
(ko)
|
2010-02-08 |
2017-10-11 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Rantes를 암호화하는 핵산 분자, 그리고 이를 포함하는 조성물 및 이의 사용 방법
|
AU2011325893B2
(en)
|
2010-11-12 |
2016-01-14 |
Inovio Pharmaceuticals, Inc |
Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same
|
JP6099573B2
(ja)
|
2011-01-31 |
2017-03-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
新規なヘルペス抗原をコードする核酸分子、それを含むワクチン及びその使用方法
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
PT2672992T
(pt)
|
2011-02-11 |
2020-07-27 |
Univ Pennsylvania |
Molécula de ácidos nucleicos codificando proteína nuclear do vírus da hepatite b e vacina compreendendo a mesma
|
EA027236B1
(ru)
|
2011-04-08 |
2017-07-31 |
Иммьюн Дизайн Корп. |
Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
|
US9267112B2
(en)
|
2011-05-10 |
2016-02-23 |
The Regents Of The University Of California |
Adenovirus isolated from Titi Monkeys
|
US10221218B2
(en)
|
2011-05-10 |
2019-03-05 |
The Regents Of The University Of California |
Adenovirus isolated from titi monkeys
|
US20150030586A1
(en)
|
2011-06-21 |
2015-01-29 |
Sarah Ellen Warren |
Compositions and methods for the therapy and diagnosis of cancer
|
CA2841852C
(en)
|
2011-07-11 |
2020-06-30 |
Inovio Pharmaceuticals, Inc. |
Cross-protective arenavirus vaccines and their method of use
|
HUE035774T2
(en)
|
2011-08-12 |
2018-05-28 |
Merial Inc |
Biological substances, in particular vaccines, preserved by vacuum
|
CA2846865A1
(en)
|
2011-08-29 |
2013-03-07 |
The Regents Of The University Of California |
Use of hdl-related molecules to treat and prevent proinflammatory conditions
|
EP3443982A1
(en)
|
2011-10-12 |
2019-02-20 |
The Trustees of the University of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
KR101679731B1
(ko)
|
2011-10-24 |
2016-11-25 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 hcv 백신 및 이것을 사용하는 방법
|
US9750795B2
(en)
|
2011-12-12 |
2017-09-05 |
The Trustees Of The University Of Pennsylvania |
Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections
|
EP3336096A1
(en)
|
2011-12-12 |
2018-06-20 |
The Trustees Of The University Of Pennsylvania |
Compositions, comprising improved il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
|
ES2729967T3
(es)
|
2012-02-07 |
2019-11-07 |
Infectious Disease Res Inst |
Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
|
CN104619719A
(zh)
|
2012-04-10 |
2015-05-13 |
宾夕法尼亚大学理事会 |
人呼吸道合胞病毒共有抗原、由其制备的核酸构建体和疫苗及其使用方法
|
SG11201406592QA
(en)
|
2012-05-04 |
2014-11-27 |
Pfizer |
Prostate-associated antigens and vaccine-based immunotherapy regimens
|
EP3388835B1
(en)
|
2012-05-16 |
2020-04-01 |
Immune Design Corp. |
Vaccines for hsv-2
|
WO2014031178A1
(en)
|
2012-08-24 |
2014-02-27 |
Etubics Corporation |
Replication defective adenovirus vector in vaccination
|
EA034056B1
(ru)
|
2013-03-12 |
2019-12-23 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Усовершенствованные вакцины против вируса папилломы человека и способы их применения
|
WO2014144844A1
(en)
|
2013-03-15 |
2014-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
tRNA DERIVED SMALL RNAs (tsRNAs) INVOLVED IN CELL VIABILITY
|
KR20210088754A
(ko)
|
2013-03-15 |
2021-07-14 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
구제역 바이러스 (fmdv) 공통 단백질, 그에 대한 코딩 서열 및 그로부터 제조된 백신
|
EA034110B1
(ru)
|
2013-03-15 |
2019-12-27 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Противораковые вакцины и способы лечения с их применением
|
BR112015023500B1
(pt)
|
2013-03-15 |
2021-01-12 |
The Regents Of The University Of California |
composição farmacêutica
|
CN105209047B
(zh)
|
2013-04-18 |
2020-08-18 |
免疫设计股份有限公司 |
用于癌症治疗的gla单一疗法
|
JP2016518126A
(ja)
|
2013-04-19 |
2016-06-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ローンスターウイルス
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
US10231993B2
(en)
|
2013-06-27 |
2019-03-19 |
University Of Washington Through Its Center For Commercialization |
Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
|
CA2953917C
(en)
|
2013-07-01 |
2021-10-19 |
The Research Foundation For The State University Of New York |
Ship inhibition to combat obesity
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
EP3157529B1
(en)
|
2014-06-17 |
2021-08-04 |
The Research Foundation for The State University of New York |
Ship inhibition to induce activation of natural killer cells
|
ES2753573T3
(es)
|
2014-06-27 |
2020-04-13 |
Abbott Lab |
Composiciones y métodos para detectar pegivirus humano 2 (HPGV-2)
|
JP2018511655A
(ja)
|
2015-03-20 |
2018-04-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
ボルデテラ属に対するワクチン接種における使用のための免疫原性組成物
|
US11352426B2
(en)
|
2015-09-21 |
2022-06-07 |
Aptevo Research And Development Llc |
CD3 binding polypeptides
|
US10548970B2
(en)
|
2015-10-05 |
2020-02-04 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human rotavirus G9P[6] strain and use as a vaccine
|
AU2017206102C1
(en)
|
2016-01-08 |
2022-02-10 |
Geovax Inc. |
Compositions and methods for generating an immune response to a tumor associated antigen
|
ES2811523T3
(es)
|
2016-01-19 |
2021-03-12 |
Pfizer |
Vacunas contra el cáncer
|
EP4112638A1
(en)
|
2016-05-16 |
2023-01-04 |
Access to Advanced Health Institute |
Formulation containing tlr agonist and methods of use
|
CA3026054A1
(en)
|
2016-05-30 |
2017-12-07 |
Geovax Inc. |
Compositions and methods for generating an immune response to hepatitis b virus
|
MX2018014399A
(es)
|
2016-06-01 |
2019-06-06 |
Infectious Disease Res Inst |
Particulas de nanoalumbre que contienen un agente de dimensionamiento.
|
PE20200613A1
(es)
|
2017-07-11 |
2020-03-11 |
Pfizer |
Composiciones inmunogenicas
|
KR20200041897A
(ko)
|
2017-08-01 |
2020-04-22 |
에이비 스튜디오 인코포레이티드 |
이중특이 항체 및 그의 용도
|
KR20240023192A
(ko)
|
2017-11-24 |
2024-02-20 |
유큐(베이징) 바이오파마 코., 엘티디 |
항―ox40 항체 및 그의 용도
|
EP3723812A4
(en)
|
2017-12-13 |
2022-02-16 |
Inovio Pharmaceuticals, Inc. |
MUC16-TARGETING CANCER VACCINES AND THEIR USES
|
EP3737397B1
(en)
|
2017-12-13 |
2022-11-30 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting prame and uses thereof
|
AU2018383658B2
(en)
|
2017-12-13 |
2022-02-10 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting mesothelin and uses thereof
|
CA3091352A1
(en)
|
2018-02-21 |
2019-08-29 |
The University Of Montana |
Diaryl trehalose compounds and uses thereof
|
EP3755716A4
(en)
|
2018-02-23 |
2021-08-04 |
Eucure (Beijing) Biopharma Co., Ltd |
ANTI-PD-1 ANTIBODIES AND THEIR USES
|
WO2019169313A1
(en)
|
2018-03-02 |
2019-09-06 |
The University Of Montana |
Immunogenic trehalose compounds and uses thereof
|
CN112566933B
(zh)
|
2018-07-20 |
2023-07-14 |
祐和医药科技(北京)有限公司 |
抗cd40抗体及其用途
|
BR112021004698A2
(pt)
|
2018-09-12 |
2021-06-01 |
Eucure (Beijing) Biopharma Co., Ltd |
anticorpos anti-tnfrsf9 e usos dos mesmos
|
SG11202105153RA
(en)
|
2018-11-19 |
2021-06-29 |
Biocytogen Pharmaceuticals Beijing Co Ltd |
Anti-pd-1 antibodies and uses thereof
|
CN117099741A
(zh)
|
2019-02-18 |
2023-11-24 |
百奥赛图(北京)医药科技股份有限公司 |
具有人源化免疫球蛋白基因座的经遗传修饰的非人动物
|
US20220241410A1
(en)
|
2019-05-23 |
2022-08-04 |
The University Of Montana |
Vaccine adjuvants based on tlr receptor ligands
|
WO2021244522A1
(en)
|
2020-06-02 |
2021-12-09 |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
Genetically modified non-human animals with common light chain immunoglobulin locus
|